Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *


Products » Items » Hizentra 2g/10ml


May be acceptable

May be acceptable
Use with caution
Hizentra 2g/10ml :
Type Medicine Authorised
Originator BioHuman (Human Ig 2g/10ml)
Agent Benta Trading Co
Distributor Benta Trading Co
Laboratory CSL Behring
Manufacturer Benta SAL
Manufacturing Type Packaging
Origin Lebanon
ATC J06BA02

Your comment will appear shortly after approval


Different Units By MoH Code

Revision Date : 01/07/2018

Hizentra 2g/10ml  MoH 9717 :
Form Solution for injection
Packaging Bottle
Package Size 10ml
Strength 2g/10ml
Public Price 17082458,12 L.L.
Stratum D
NSSF
Quarantine
Reg. Number 172618/1
Submission date 01/01/2018
Registration Year 2019




NB : Reregistration in 2019 with local manufacturer


Price Comparison

Country: Lebanon
Form: Solution for injection
Package Size: 10ml
Public Price: 17082458.12 LBP ( 17,082,458.12 LBP )
Pack size unit used: 10
Cost/Unit: 1708245,81 LBP ( 1,708,245.00 LBP )
Pricing Date: 10/01/2024

Country: Denmark
Package Size: 1x10 ml
Public Price: 1136.65 DKK ( 2,797,261.55 LBP )
Pack size unit used: 10
Cost/Unit: 113,665 DKK ( 278,089.61 LBP )
Pharmacy Price: 840 DKK ( 2067214.8 LBP )
Reference: Danish Medicine Agency
Pricing Date: 19/05/2021
Type: Medicine Authorised

Country: Cyprus
Package Size: 1x10ml
Public Price: 159.2 EUR ( 2,926,103.96 LBP )
Pack size unit used: 10
Cost/Unit: 15,92 EUR ( 275,700.75 LBP )
Reference: Cyprus Minister of Health
Pricing Date: 24/03/2021
Type: Medicine Authorised

Country: Germany
Package Size: 10x10ml
Public Price: 1516.69 EUR ( 27,876,838.03 LBP )
Pack size unit used: 100
Cost/Unit: 15,1669 EUR ( 275,700.75 LBP )
Pricing Date: 24/10/2020
Type: Medicine Authorised

Country: UK
Package Size: 1x10ml
Public Price: 138 GBP ( 2,780,806.26 LBP )
Pack size unit used: 10
Cost/Unit: 13,8 GBP ( 261,960.01 LBP )
Reference: DMD
Pricing Date: 08/03/2021
Type: Medicine Authorised

Country: Spain
Package Size: 10 x10 ml
Reference: Agencia Española de Medicamentos y Productos Sanitarios
Pricing Date: 06/05/2021
Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries


Note

Common variable immunodeficiency :
Cost/Unit: 1708245,81 LBP ( 1,708,245.00 LBP )
Cost/Day: 47830882,68 LBP ( 47,830,882.00 LBP )
Cost/Month: 956617653,6 LBP ( 956,617,653.00 LBP )
Congenital agammaglobulinaemia : (Adults)
Cost/Unit: 1708245,81 LBP ( 1,708,245.00 LBP )
Cost/Day: 47830882,68 LBP ( 47,830,882.00 LBP )
Cost/Month: 956617653,6 LBP ( 956,617,653.00 LBP )
Congenital hypogammaglobulinaemia :
Cost/Unit: 1708245,81 LBP ( 1,708,245.00 LBP )
Cost/Day: 47830882,68 LBP ( 47,830,882.00 LBP )
Cost/Month: 956617653,6 LBP ( 956,617,653.00 LBP )
IgG subclass deficiencies :
Cost/Unit: 1708245,81 LBP ( 1,708,245.00 LBP )
Cost/Day: 47830882,68 LBP ( 47,830,882.00 LBP )
Cost/Month: 956617653,6 LBP ( 956,617,653.00 LBP )
Primary immunodeficiency syndromes :
Cost/Unit: 1708245,81 LBP ( 1,708,245.00 LBP )
Cost/Day: 47830882,68 LBP ( 47,830,882.00 LBP )
Cost/Month: 956617653,6 LBP ( 956,617,653.00 LBP )
Replacement therapy in chronic lymphocytic leukaemia : (Adults)
Cost/Unit: 1708245,81 LBP ( 1,708,245.00 LBP )
Cost/Day: 47830882,68 LBP ( 47,830,882.00 LBP )
Cost/Month: 956617653,6 LBP ( 956,617,653.00 LBP )
Replacement therapy in myeloma : (Adults)
Cost/Unit: 1708245,81 LBP ( 1,708,245.00 LBP )
Cost/Day: 47830882,68 LBP ( 47,830,882.00 LBP )
Cost/Month: 956617653,6 LBP ( 956,617,653.00 LBP )
Severe combined immunodeficiency :
Cost/Unit: 1708245,81 LBP ( 1,708,245.00 LBP )
Cost/Day: 47830882,68 LBP ( 47,830,882.00 LBP )
Cost/Month: 956617653,6 LBP ( 956,617,653.00 LBP )
Common variable immunodeficiency :
Cost/Unit: 113,665 DKK ( 278,089.61 LBP )
Cost/Day: 3182,62 DKK ( 7,830,806.54 LBP )
Cost/Month: 63652,4 DKK ( 156,645,662.44 LBP )
Congenital agammaglobulinaemia : (Adults)
Cost/Unit: 113,665 DKK ( 278,089.61 LBP )
Cost/Day: 3182,62 DKK ( 7,830,806.54 LBP )
Cost/Month: 63652,4 DKK ( 156,645,662.44 LBP )
Congenital hypogammaglobulinaemia :
Cost/Unit: 113,665 DKK ( 278,089.61 LBP )
Cost/Day: 3182,62 DKK ( 7,830,806.54 LBP )
Cost/Month: 63652,4 DKK ( 156,645,662.44 LBP )
IgG subclass deficiencies :
Cost/Unit: 113,665 DKK ( 278,089.61 LBP )
Cost/Day: 3182,62 DKK ( 7,830,806.54 LBP )
Cost/Month: 63652,4 DKK ( 156,645,662.44 LBP )
Primary immunodeficiency syndromes :
Cost/Unit: 113,665 DKK ( 278,089.61 LBP )
Cost/Day: 3182,62 DKK ( 7,830,806.54 LBP )
Cost/Month: 63652,4 DKK ( 156,645,662.44 LBP )
Replacement therapy in chronic lymphocytic leukaemia : (Adults)
Cost/Unit: 113,665 DKK ( 278,089.61 LBP )
Cost/Day: 3182,62 DKK ( 7,830,806.54 LBP )
Cost/Month: 63652,4 DKK ( 156,645,662.44 LBP )
Replacement therapy in myeloma : (Adults)
Cost/Unit: 113,665 DKK ( 278,089.61 LBP )
Cost/Day: 3182,62 DKK ( 7,830,806.54 LBP )
Cost/Month: 63652,4 DKK ( 156,645,662.44 LBP )
Severe combined immunodeficiency :
Cost/Unit: 113,665 DKK ( 278,089.61 LBP )
Cost/Day: 3182,62 DKK ( 7,830,806.54 LBP )
Cost/Month: 63652,4 DKK ( 156,645,662.44 LBP )
Common variable immunodeficiency :
Cost/Unit: 15,1669 EUR ( 275,700.75 LBP )
Cost/Day: 424,67 EUR ( 7,793,141.20 LBP )
Cost/Month: 8493,4 EUR ( 156,101,764.65 LBP )
Congenital agammaglobulinaemia : (Adults)
Cost/Unit: 15,1669 EUR ( 275,700.75 LBP )
Cost/Day: 424,67 EUR ( 7,793,141.20 LBP )
Cost/Month: 8493,4 EUR ( 156,101,764.65 LBP )
Congenital hypogammaglobulinaemia :
Cost/Unit: 15,1669 EUR ( 275,700.75 LBP )
Cost/Day: 424,67 EUR ( 7,793,141.20 LBP )
Cost/Month: 8493,4 EUR ( 156,101,764.65 LBP )
IgG subclass deficiencies :
Cost/Unit: 15,1669 EUR ( 275,700.75 LBP )
Cost/Day: 424,67 EUR ( 7,793,141.20 LBP )
Cost/Month: 8493,4 EUR ( 156,101,764.65 LBP )
Primary immunodeficiency syndromes :
Cost/Unit: 15,1669 EUR ( 275,700.75 LBP )
Cost/Day: 424,67 EUR ( 7,793,141.20 LBP )
Cost/Month: 8493,4 EUR ( 156,101,764.65 LBP )
Replacement therapy in chronic lymphocytic leukaemia : (Adults)
Cost/Unit: 15,1669 EUR ( 275,700.75 LBP )
Cost/Day: 424,67 EUR ( 7,793,141.20 LBP )
Cost/Month: 8493,4 EUR ( 156,101,764.65 LBP )
Replacement therapy in myeloma : (Adults)
Cost/Unit: 15,1669 EUR ( 275,700.75 LBP )
Cost/Day: 424,67 EUR ( 7,793,141.20 LBP )
Cost/Month: 8493,4 EUR ( 156,101,764.65 LBP )
Severe combined immunodeficiency :
Cost/Unit: 15,1669 EUR ( 275,700.75 LBP )
Cost/Day: 424,67 EUR ( 7,793,141.20 LBP )
Cost/Month: 8493,4 EUR ( 156,101,764.65 LBP )
Common variable immunodeficiency :
Cost/Unit: 15,92 EUR ( 275,700.75 LBP )
Cost/Day: 445,76 EUR ( 8,179,122.25 LBP )
Cost/Month: 8915,2 EUR ( 163,858,145.75 LBP )
Congenital agammaglobulinaemia : (Adults)
Cost/Unit: 15,92 EUR ( 275,700.75 LBP )
Cost/Day: 445,76 EUR ( 8,179,122.25 LBP )
Cost/Month: 8915,2 EUR ( 163,858,145.75 LBP )
Congenital hypogammaglobulinaemia :
Cost/Unit: 15,92 EUR ( 275,700.75 LBP )
Cost/Day: 445,76 EUR ( 8,179,122.25 LBP )
Cost/Month: 8915,2 EUR ( 163,858,145.75 LBP )
IgG subclass deficiencies :
Cost/Unit: 15,92 EUR ( 275,700.75 LBP )
Cost/Day: 445,76 EUR ( 8,179,122.25 LBP )
Cost/Month: 8915,2 EUR ( 163,858,145.75 LBP )
Primary immunodeficiency syndromes :
Cost/Unit: 15,92 EUR ( 275,700.75 LBP )
Cost/Day: 445,76 EUR ( 8,179,122.25 LBP )
Cost/Month: 8915,2 EUR ( 163,858,145.75 LBP )
Replacement therapy in chronic lymphocytic leukaemia : (Adults)
Cost/Unit: 15,92 EUR ( 275,700.75 LBP )
Cost/Day: 445,76 EUR ( 8,179,122.25 LBP )
Cost/Month: 8915,2 EUR ( 163,858,145.75 LBP )
Replacement therapy in myeloma : (Adults)
Cost/Unit: 15,92 EUR ( 275,700.75 LBP )
Cost/Day: 445,76 EUR ( 8,179,122.25 LBP )
Cost/Month: 8915,2 EUR ( 163,858,145.75 LBP )
Severe combined immunodeficiency :
Cost/Unit: 15,92 EUR ( 275,700.75 LBP )
Cost/Day: 445,76 EUR ( 8,179,122.25 LBP )
Cost/Month: 8915,2 EUR ( 163,858,145.75 LBP )
Common variable immunodeficiency :
Cost/Unit: 13,8 GBP ( 261,960.01 LBP )
Cost/Day: 386,4 GBP ( 7,778,197.22 LBP )
Cost/Month: 7728 GBP ( 155,725,150.56 LBP )
Congenital agammaglobulinaemia : (Adults)
Cost/Unit: 13,8 GBP ( 261,960.01 LBP )
Cost/Day: 386,4 GBP ( 7,778,197.22 LBP )
Cost/Month: 7728 GBP ( 155,725,150.56 LBP )
Congenital hypogammaglobulinaemia :
Cost/Unit: 13,8 GBP ( 261,960.01 LBP )
Cost/Day: 386,4 GBP ( 7,778,197.22 LBP )
Cost/Month: 7728 GBP ( 155,725,150.56 LBP )
IgG subclass deficiencies :
Cost/Unit: 13,8 GBP ( 261,960.01 LBP )
Cost/Day: 386,4 GBP ( 7,778,197.22 LBP )
Cost/Month: 7728 GBP ( 155,725,150.56 LBP )
Primary immunodeficiency syndromes :
Cost/Unit: 13,8 GBP ( 261,960.01 LBP )
Cost/Day: 386,4 GBP ( 7,778,197.22 LBP )
Cost/Month: 7728 GBP ( 155,725,150.56 LBP )
Replacement therapy in chronic lymphocytic leukaemia : (Adults)
Cost/Unit: 13,8 GBP ( 261,960.01 LBP )
Cost/Day: 386,4 GBP ( 7,778,197.22 LBP )
Cost/Month: 7728 GBP ( 155,725,150.56 LBP )
Replacement therapy in myeloma : (Adults)
Cost/Unit: 13,8 GBP ( 261,960.01 LBP )
Cost/Day: 386,4 GBP ( 7,778,197.22 LBP )
Cost/Month: 7728 GBP ( 155,725,150.56 LBP )
Severe combined immunodeficiency :
Cost/Unit: 13,8 GBP ( 261,960.01 LBP )
Cost/Day: 386,4 GBP ( 7,778,197.22 LBP )
Cost/Month: 7728 GBP ( 155,725,150.56 LBP )

Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info